• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

MassDevice Earnings Roundup

Tandem stock rises on 31% Q3 sales growth, raised guidance

November 6, 2024 By Sean Whooley

Tandem Diabetes Care updated logo

Tandem Diabetes Care (Nasdaq:TNDM) shares ticked up after hours today on third-quarter results that topped the consensus forecast. Shares of TNDM rose 5% to $35.85 apiece in post-market trading today. The San Diego-based automated insulin delivery system maker reported losses of $23.3 million. That equals 35¢ per share on sales of nearly $244 million for […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

Dexcom submits 15-day CGM to FDA, beats Street in Q3

October 25, 2024 By Sean Whooley

Dexcom G7 iPhone (1)

Dexcom (Nasdaq:DXCM) announced that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA. G7, the company’s latest-generation continuous glucose monitor (CGM), presently has approval for a 10-day wear time. Shares of DXCM were up slightly at the opening of trading today. Yesterday evening, Dexcom also reported third-quarter results […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), MassDevice Earnings Roundup, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Dexcom

Medtronic wants to be No. 1 in automated insulin delivery as Q1 results highlight Diabetes growth

August 20, 2024 By Sean Whooley

Medtronic MiniMed 780G automated insulin delivery system with Simplera Sync CGM Sensor

Medtronic (NYSE:MDT) reported more growth in its Diabetes unit as the company’s recent moves signal its intent in the competitive insulin pump market. The company’s first-quarter (fiscal 2025) results included $647 million in revenue from the Diabetes unit. That marked 11% year-over-year growth from the same three-month period a year ago. U.S. revenues grew in […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Medtronic

Embecta stock gets a boost on Q3 beats, patch pump program remains on track

August 9, 2024 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) shares rose significantly today on third-quarter results that came in well ahead of the consensus forecast. Shares of EMBC ticked up 14% to $16.39 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. It’s the second recent boost for Embecta’s […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: embecta

Senseonics misses Q2 sales expectations but 365-day CGM is on track for Q4 launch

August 8, 2024 By Sean Whooley

Ascensia Senseonics Eversense E3 implantable long-term CGM

Senseonics (NYSE:SENS) shares dipped after hours today on second-quarter results that missed the consensus sales forecast. Shares of SENS  fell 4% to 39¢ apiece in post-market trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day up nearly 1%. The Germantown, Maryland-based long-term implantable […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Senseonics

Insulet reports Omnipod sales growth of 26% in Q2, raises guidance despite EPS miss

August 8, 2024 By Sean Whooley

Insulet logo

Insulet (Nasdaq:PODD) stock is down on second-quarter results that came in mixed compared to the consensus forecast. Shares of PODD were down more than 7% to $184.56 apiece by midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up slightly. Yesterday evening, the Acton, […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Insulet

Tandem stock soars after hours on Q2 beats, increased guidance as pump shipments rise again

August 1, 2024 By Sean Whooley

Tandem Diabetes Care updated logo

Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost after the market closed today on second-quarter results that beat the consensus forecast. Shares of TNDM rose more than 22% to $43.20 apiece in post-market trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

Insulet preliminary Q2 revenue report beats The Street

July 26, 2024 By Chris Newmarker

Insulet logo

Insulet (Nasdaq: PODD) saw its revenue increase 23% year-over-year to $488 million in the second quarter, which ended June 30. That’s according to preliminary Q2 revenue numbers that Insulet released today. The result beats the consensus of Wall Street analysts, who expected that Insulet had $460.27 million in revenue in Q2. The maker of Omnipod […]

Filed Under: Business/Financial News, Diabetes, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Insulet

Dexcom stock falls on Q2 results that came up shy of ‘high standards’

July 26, 2024 By Sean Whooley

Dexcom updated Logo

Dexcom (Nasdaq:DXCM) (Nasdaq:DXCM) shares plummeted today on second-quarter results that came in mixed compared to the consensus forecast. Shares of DXCM fell more than 40% to $63.96 apiece in morning trading today. MassDevice‘s MedTech 100 Index was down slightly. The San Diego-based continuous glucose monitor (CGM) maker yesterday evening reported profits of $143.5 million. That […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

Senseonics posts Q1 sales beat, submits 365-day iCGM to FDA

May 13, 2024 By Sean Whooley

Senseonics logo

Senseonics (NYSE:SENS) shares ticked up after the market closed today on first-quarter results that came in ahead of the consensus sales forecast. Shares of SENS rose 8.1% to 41¢ apiece in post-market trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down slightly. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Senseonics

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 38
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS